Dogwood Therapeutics, Inc. (DWTX) Ownership

NASDAQ: DWTXTop holders, insider trades and short interest.

DWTX ownership summary

as of October 18, 2026
Institutions
11.5%
of shares outstanding
Insiders
72.57%
of shares outstanding
Shares outstanding
34.0M
Float
5.8M
shares available to trade
Short interest
0.32%
39K shares short
Days to cover
0.58
short interest down 47.6% vs prior month
  • Institutions 11.47%
  • Insiders 72.57%
  • Other investors 15.96%

DWTX top institutional holders

20 largest
Dogwood Therapeutics, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Armistice Capital, LLC9.22%3.1M$3.8M−147,514 (−4.5%)June 30, 2026
2Millennium Management LLC1.01%342K$417,013+341,814 (0.0%)June 30, 2026
3Vanguard Capital Management, LLC0.39%132K$161,228—June 30, 2026
4Geode Capital Management, LLC0.26%88K$107,724+8,864 (+11.2%)June 30, 2026
5Vanguard Fiduciary Trust Co0.18%63K$76,538—June 30, 2026
6BlackRock Inc0.08%29K$34,826+28,516 (+95,053.3%)June 30, 2026
7Northern Trust Corp0.07%24K$29,010—June 30, 2026
8Citadel Advisors Llc0.03%12K$14,325+11,742 (0.0%)June 30, 2026
9Tower Research Capital LLC0.01%3,093$3,773−4,974 (−61.7%)June 30, 2026
10Morgan Stanley - Brokerage Accounts0.01%2,222$2,711+2,222 (0.0%)June 30, 2026
11UBS Group AG0.01%1,860$2,269−5,225 (−73.7%)June 30, 2026
12Mercer Global Advisors Inc.<0.01%550$671+550 (0.0%)June 30, 2026
13JONES FINANCIAL COMPANIES LLLP<0.01%160$195+160 (0.0%)June 30, 2026
14Barclays PLC<0.01%157$192+157 (0.0%)June 30, 2026
15Activest Wealth Management<0.01%120$146—June 30, 2026
16Group One Trading, LLC0.00%9$11—June 30, 2026
17The Goldman Sachs Group Inc0.00%——−14,598 (−100.0%)June 30, 2026
18BNP Paribas Arbitrage, SA0.00%——−2 (−100.0%)June 30, 2026
19Marshall Wace Asset Management Ltd0.00%——−11,756 (−100.0%)June 30, 2026
20Bank of America Corp0.00%——−9,415 (−100.0%)March 31, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 8 holders added 394K shares and 7 cut 193K.

DWTX top mutual fund and ETF holders

6 largest
Dogwood Therapeutics, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Fidelity Extended Market Index0.17%57K$69,136−305 (−0.5%)August 31, 2026
2iShares Micro-Cap ETF0.07%25K$30,987−175 (−0.7%)September 30, 2026
3Fidelity Series Total Market Index0.04%13K$15,932—August 31, 2026
4Fidelity Total Market Index0.01%4,586$5,595+2,292 (+99.9%)August 31, 2026
5Fidelity Nasdaq Composite Index0.01%3,769$4,598—August 31, 2026
61290 VT Micro Cap K0.01%1,892$2,308—August 31, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

DWTX shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns DWTX

Institutional investors own 11.5% of Dogwood Therapeutics's shares and insiders 72.57%. The largest holder is Armistice Capital, LLC with 9.22% of the shares (3.1M), as of June 30, 2026. Among the top 20 institutions, 8 added shares and 7 reduced their stake in the latest filings. Short interest is 0.32% of the float, or 0.58 days of average trading volume. The share count rose 7,412.3% since 2019.

Related: DWTX analyst forecast, DWTX key metrics. See the DWTX stock overview for the latest quote and news.

DWTX ownership FAQ

Who owns the most Dogwood Therapeutics stock?

The largest shareholders of Dogwood Therapeutics are Armistice Capital, LLC (9.22%), Millennium Management LLC (1.01%), Vanguard Capital Management, LLC (0.39%), Geode Capital Management, LLC (0.26%), Vanguard Fiduciary Trust Co (0.18%).

What percentage of Dogwood Therapeutics is owned by institutions?

Institutions hold 11.5% of Dogwood Therapeutics's shares outstanding; insiders hold 72.57%.

Which funds own Dogwood Therapeutics?

The largest fund holders of Dogwood Therapeutics are Fidelity Extended Market Index (0.17%), iShares Micro-Cap ETF (0.07%), Fidelity Series Total Market Index (0.04%), Fidelity Total Market Index (0.01%), Fidelity Nasdaq Composite Index (0.01%).

What is Dogwood Therapeutics's short interest?

39K shares of Dogwood Therapeutics were sold short, 0.32% of the float; at the average daily volume it would take 0.58 days to cover.

How many shares of Dogwood Therapeutics are outstanding?

Dogwood Therapeutics has 34.0M shares outstanding, of which 5.8M are in the public float.

Biotechnology: ownership